Women with preeclampsia may have reduced risk of breast cancer: a meta-analysis of cohort studies with 7.8 million participants

References

• Malik A, Jee B, Gupta SK. Preeclampsia: disease biology and burden, its management strategies with reference to India. Pregnancy Hypertens. 2019;15:23–8. doi: 10.1016/J.PREGHY.2018.10.011
   PubMed Web of Science ®Google Scholar
• Bokslag A, van Weissenbruch M, Mol BW, et al. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev. 2016;102:47–50. doi: 10.1016/J.EARLHUMDEV.2016.09.007
   PubMed Web of Science ®Google Scholar
• Tomimatsu T, Mimura K, Matsuzaki S, et al. Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors. Int J Mol Sci. 2019;20(17):4246. doi: 10.3390/IJMS20174246
   PubMed Web of Science ®Google Scholar
• Paauw ND, Lely AT. Cardiovascular sequels during and after preeclampsia. Adv Exp Med Biol. 2018;1065:455–470. doi: 10.1007/978-3-319-77932-4_28
   PubMed Web of Science ®Google Scholar
• Calderon-Margalit R, Friedlander Y, Yanetz R, et al. Preeclampsia and subsequent risk of cancer: update from the Jerusalem perinatal study. Am J Obstet Gynecol. 2009;200(1):0.e63.1–0.e63.5. doi: 10.1016/J.AJOG.2008.06.057
   Web of Science ®Google Scholar
• Walfisch A, Kessous R, Davidson E, et al. Pre-eclampsia and future female malignancy. Hypertens Pregnancy. 2015;34(4):456–463. doi: 10.3109/10641955.2015.1071838
   PubMed Web of Science ®Google Scholar
• Nichols HB, House MG, Yarosh R, et al. Hypertensive conditions of pregnancy, preterm birth, and premenopausal breast cancer risk: a premenopausal breast cancer collaborative group analysis. Breast Cancer Res Treat. 2023;199(2):323–334. doi: 10.1007/S10549-023-06903-5
   PubMedGoogle Scholar
• Yang H, He W, Eriksson M, et al. Inherited factors contribute to an inverse association between preeclampsia and breast cancer. Breast Cancer Res. 2018;20(1). doi: 10.1186/S13058-017-0930-6
   Google Scholar
• Jobe SO, Tyler CT, Magness RR. Aberrant synthesis, metabolism, and plasma accumulation of circulating estrogens and estrogen metabolites in preeclampsia implications for vascular dysfunction. Hypertens (Dallas, Tex 1979). 2013;61(2):480–487. doi: 10.1161/HYPERTENSIONAHA.111.201624
   PubMed Web of Science ®Google Scholar
• Sun M, Fan Y, Hou Y, et al. Preeclampsia and maternal risk of breast cancer: a meta-analysis of cohort studies. J Matern Fetal Neonatal Med. 2018;31(18):2484–2491. doi: 10.1080/14767058.2017.1342806
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2020 October 30. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. doi: 10.1016/j.ijsu.2021.105906
   PubMed Web of Science ®Google Scholar
• Mogren I. Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer. Acta Oncol. 2001;40(7):849–854. doi: 10.1080/02841860152703481
   PubMed Web of Science ®Google Scholar
• Cohn BA, Cirillo PM, Christianson RE, et al. Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst. 2001;93:1133–1140. doi: 10.1093/JNCI/93.15.1133
   PubMed Web of Science ®Google Scholar
• Ma H, Henderson KD, Sullivan-Halley J, et al. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California teachers study cohort. Breast Cancer Res. 2010;12(3). doi: 10.1186/BCR2589
   Web of Science ®Google Scholar
• Bhattacharya S, Prescott GJ, Iversen L, et al. Hypertensive disorders of pregnancy and future health and mortality: a record linkage study. Pregnancy Hypertens. 2012;2(1):1–7. doi: 10.1016/J.PREGHY.2011.08.116
   PubMed Web of Science ®Google Scholar
• Opdahl S, Romundstad PR, Alsaker MDK, et al. Hypertensive diseases in pregnancy and breast cancer risk. Br J Cancer. 2012;107(1):176–182. doi: 10.1038/BJC.2012.195
   PubMed Web of Science ®Google Scholar
• Pacheco NLP, Andersen AMN, Kamper-Jørgensen M. Preeclampsia and breast cancer: the influence of birth characteristics. Breast. 2015;24(5):613–617. doi: 10.1016/J.BREAST.2015.06.006
   PubMed Web of Science ®Google Scholar
• Serrand C, Mura T, Fabbro-Peray P, et al. Assessment of all-cause cancer incidence among individuals with preeclampsia or eclampsia during first pregnancy. JAMA Netw Open. 2021;4(6):e2114486. doi: 10.1001/JAMANETWORKOPEN.2021.14486
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang W, Cheng W, et al. Preeclampsia and cancer risk in women in later life: a systematic review and meta-analysis of cohort studies. Menopause. 2021;28(9):1070–1078. doi: 10.1097/GME.0000000000001806
   PubMed Web of Science ®Google Scholar
• Jordao H, Herink K, Ka E, et al. Pre-eclampsia during pregnancy and risk of endometrial cancer: a systematic review and meta-analysis. BMC Womens Health. 2023;23: doi: 10.1186/S12905-023-02408-X
   PubMed Web of Science ®Google Scholar
• Boij R, Svensson J, Nilsson-Ekdahl K, et al. Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia. Am J Reprod Immunol. 2012;68(3):258–270. doi: 10.1111/J.1600-0897.2012.01158.X
   PubMed Web of Science ®Google Scholar
• Palm M, Basu S, Larsson A, et al. A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy. Acta Obstet Gynecol Scand. 2011;90(11):1244–1251. doi: 10.1111/J.1600-0412.2011.01186.X
   PubMed Web of Science ®Google Scholar
• Redman CWG, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009;30(Suppl A):38–42. doi: 10.1016/J.PLACENTA.2008.11.021
   PubMed Web of Science ®Google Scholar
• Fantone S, Mazzucchelli R, Giannubilo SR, et al. AT-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsia. Histochem Cell Biol. 2020;154(3):339–346. doi: 10.1007/S00418-020-01892-8
   PubMed Web of Science ®Google Scholar
• Tossetta G, Fantone S, Piani F, et al. Modulation of NRF2/KEAP1 signaling in preeclampsia. Cells. 2023;12(11):1545. doi: 10.3390/CELLS12111545
   PubMed Web of Science ®Google Scholar
• Troisi R, Braekke K, Harsem NK, et al. Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies. Am J Obstet Gynecol. 2008;199(6):.e653.1–.e653.10. doi: 10.1016/J.AJOG.2008.06.030
   Web of Science ®Google Scholar
• Kristensen VN, Vaske CJ, Ursini-Siegel J, et al. Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling. Proc Natl Acad Sci U S A. 2012;109(8):2802–2807. doi: 10.1073/PNAS.1108781108
   PubMed Web of Science ®Google Scholar
• Maae E, Olsen DA, Steffensen KD, et al. Prognostic impact of placenta growth factor and vascular endothelial growth factor a in patients with breast cancer. Breast Cancer Res Treat. 2012;133(1):257–265. doi: 10.1007/S10549-012-1957-0
   PubMed Web of Science ®Google Scholar
• Parr C, Watkins G, Boulton M, et al. Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer. 2005;41(18):2819–2827. doi: 10.1016/J.EJCA.2005.07.022
   PubMed Web of Science ®Google Scholar
• Varella L, Abraham J, Kruse M. Revisiting the role of bevacizumab in the treatment of breast cancer. Semin Oncol. 2017;44(4):273–285. doi: 10.1053/J.SEMINONCOL.2017.10.010
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683. doi: 10.1056/NEJMOA031884
   PubMed Web of Science ®Google Scholar
• Han H, Guo W, Shi W, et al. Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep. 2017;7(1). doi: 10.1038/SREP44877
   Google Scholar
• Yue W, Tran HT, Wang JP, et al. The hypertension related gene G-Protein coupled receptor kinase 4 contributes to breast cancer proliferation. Breast Cancer (Auckl). 2021;15:117822342110157. doi: 10.1177/11782234211015753
   Google Scholar